PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"
News Jun 07, 2006
PharmaFrontiers Corp. has announced that David B. McWilliams, chief executive officer of PharmaFrontiers, will make a presentation entitled, "Embracing the Realities of Stem Cell Commercialization," at the upcoming Marcus Evans conference.
The presentation will be given on June 9, 2006 at the Hyatt Regency Hotel in San Francisco at 3:30 pm pacific time.
A copy of the presentation will be posted to the Company's Web site following Mr. McWilliams' talk.
In his presentation, Mr. McWilliams will discuss PharmaFrontiers' proprietary stem cell technology, which uses adult pluripotent stem cells derived from patients' own circulating blood.
In addition, he will discuss the key factors for success in the commercialization of stem cell therapies and the ways in which PharmaFrontiers is able to address the challenges facing the available technologies.
Scientists have used machine learning to train computers to see parts of the cell the human eye cannot easily distinguish. Using 3D images of fluorescently labeled cells, the research team taught computers to find structures inside living cells without fluorescent labels, using only black and white images generated by an inexpensive technique known as brightfield microscopy.READ MORE
The National Institutes of Health announced the launch of a new initiative to help speed the development of cures for sickle cell disease. The Cure Sickle Cell Initiative will take advantage of the latest genetic discoveries and technological advances to move the most promising genetic-based curative therapies safely into clinical trials within five to 10 years.